The CellBrief

Cell therapy is transforming the way we treat disease – bringing hope to patients with conditions once thought incurable. But the promise of personalized medicine depends on overcoming the industry’s biggest hurdles: how to make these therapies faster, safer, and more accessible at scale.

Founded to bridge the gap between scientific innovation and real-world production, CellBri is redefining what’s possible in cell therapy manufacturing. Our company’s mission is simple yet powerful – to help therapy developers and manufacturers simplify, scale, and accelerate how life-changing cell therapies are made.

At CellBri, everything we do centers on cell therapy production. Unlike companies serving multiple therapeutic modalities or industry segments, CellBri’s entire platform, product design, and engineering roadmap are built for the unique complexities of cell-based therapies. This singular focus enables a deeper understanding of the challenges developers face, especially when moving from research, to clinical, and ultimately, to commercial scale.

From cell isolation and activation to expansion and formulation, each step in the process demands precision, consistency, and adherence to regulatory standards. CellBri’s technology was created to deliver all three – helping teams reduce manual steps, minimize variability, and ensure every batch meets the highest quality standards.

One of CellBri’s defining principles is that automation should empower – not limit – innovation. Traditional manufacturing systems often force process development teams into a one size fits all solution that can  alter cell biology or complicate tech transfer. CellBri takes a different approach.

Its automated cell processing platform is designed to grow with your needs – from early development to commercial scale – without forcing teams to overhaul existing processes. Whether you’re optimizing a new workflow or scaling up in GMP settings, CellBri provides the flexibility to adapt, evolve, and succeed at every stage of development.

This adaptability helps organizations move faster through development milestones while maintaining the control and traceability required for regulatory compliance.

CellBri’s leadership team brings decades of experience in engineering and regulatory compliance. Backed by a robust IP portfolio, the company has developed a suite of solutions that streamline manufacturing while minimizing operational and compliance risk.

That expertise translates into systems that work seamlessly across diverse therapeutic approaches, supporting the growing number of biotech and CDMO teams advancing next-generation cell therapies.

As the industry strives to make cell therapies more widely available, CellBri’s vision remains clear: to make advanced therapies accessible to all by transforming how they are made.

Through smart, scalable automation and a commitment to partnership, CellBri is empowering teams around the world to deliver on the promise of personalized medicine – faster, safer, and more efficiently than ever before.

Follow us on LinkedIn to stay connected as we continue to shape the future of cell therapy manufacturing.